There are 2949 resources available
379P - Impact of MGMT and ABCB1 single nucleotide polymorphisms on temozolomide-induced thrombocytopenia in newly diagnosed glioblastoma
Presenter: Mathieu Jamelot
Session: E-Poster Display
Resources:
Abstract
380P - Ten-year experience of the Vall d’Hebron Institute of Oncology early drug development unit (VHIO-UITM) treating patients (pts) with primary CNS tumours (pCNS)
Presenter: Nadia Saoudi Gonzalez
Session: E-Poster Display
Resources:
Abstract
381P - Adult brainstem gliomas: Clinicopathological profile and outcomes of a single center 10-year cohort
Presenter: Alice Morais
Session: E-Poster Display
Resources:
Abstract
382P - The potential utility of end-binding protein 1 (EB1) as response-predictive biomarker for lisavanbulin: Final results from a phase I study of lisavanbulin (BAL101553) in adult patients with recurrent glioblastoma (GBM)
Presenter: Crescens Tiu
Session: E-Poster Display
Resources:
Abstract
383P - A mass spectrometry-based assay for molecular profiling of gliomas and its validation on real-world clinical samples
Presenter: Tuo Wang
Session: E-Poster Display
Resources:
Abstract
384P - Immunotherapy with autologous dendritic cells as part of the complex treatment of patients with malignant gliomas
Presenter: Victor Olyushin
Session: E-Poster Display
Resources:
Abstract
385P - Molecular profiling and molecular features of progression in Chinese glioma
Presenter: Fan Fei
Session: E-Poster Display
Resources:
Abstract
386P - Oncogenic fusions in CNS gliomas assessed by next generation sequencing: The real-world experience
Presenter: Jiri Polivka
Session: E-Poster Display
Resources:
Abstract
387P - Detection of 1p/19q deletion in gliomas with high accuracy by combining sequencing depth and heterozygous SNV allele frequency
Presenter: Peng Zhao
Session: E-Poster Display
Resources:
Abstract
388P - Preclinical study of anthraquinone-derived small molecule compound in inhibiting brain cancer
Presenter: Liyun Fann
Session: E-Poster Display
Resources:
Abstract